• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[德国法定医疗保险体系中溃疡性结肠炎的费用]

[Costs of ulcerative colitis within the German Statutory Health Insurance].

作者信息

Prenzler A, Bokemeyer B, Mittendorf T, von der Schulenburg J-M Graf

机构信息

Leibniz Universität Hannover, Forschungsstelle für Gesundheitsökonomie, Hannover.

出版信息

Dtsch Med Wochenschr. 2010 Feb;135(7):281-6. doi: 10.1055/s-0029-1244848. Epub 2010 Feb 9.

DOI:10.1055/s-0029-1244848
PMID:20146156
Abstract

BACKGROUND AND OBJECTIVES

Studies estimating the costs of ulcerative colitis (UC) within the German setting are limited. The aim of this cross-sectional study was to collect data on the overall costs arising from the care of patients with UC and to quantify this expenditure as incurred by the German Statutory Health Insurance (SHI).

METHODS

Between March 2006 and July 2007 patients from 24 ambulatory gastroenterologist practices and two hospitals were enrolled in an internet-based database. Outpatient and inpatient visits, all procedures as well as drug usage were obtained from the collected data and evaluated from the perspective of the SHI, taking also into account statutory discounts and patients' co-payments. The year 2007 was selected as the pricing period.

RESULTS

Data from 519 patients with UC were collected (gender ratio 1:1; average age 46 years). The average annual cost per UC patient to the SHI is 2,477.72 Euro, 74 % of this amount results from drug usage, 10 % from inpatient care and another 10 % from ambulatory procedures. Costs increase with the severity of the disease.

CONCLUSION

This is the first study to calculate the costs caused by UC and payed by the SHI in Germany. Future research should focus on collecting longitudinal data and also on comparing the resources used in the care of patients with other inflammatory bowel diseases, such as Crohn's disease.

摘要

背景与目的

在德国环境下估算溃疡性结肠炎(UC)成本的研究有限。这项横断面研究的目的是收集UC患者护理产生的总体成本数据,并将这笔支出量化为德国法定医疗保险(SHI)所承担的费用。

方法

2006年3月至2007年7月期间,来自24家门诊胃肠病专家诊所和两家医院的患者被纳入一个基于互联网的数据库。从收集的数据中获取门诊和住院就诊、所有诊疗程序以及药物使用情况,并从SHI的角度进行评估,同时考虑法定折扣和患者的自付费用。选择2007年作为定价期。

结果

收集了519例UC患者的数据(性别比1:1;平均年龄46岁)。SHI为每位UC患者支付的年均费用为2477.72欧元,其中74%来自药物使用,10%来自住院护理,另有10%来自门诊诊疗程序。成本随疾病严重程度增加。

结论

这是第一项计算德国UC所致成本及SHI支付费用的研究。未来研究应聚焦于收集纵向数据,以及比较UC患者护理与其他炎症性肠病(如克罗恩病)患者护理所使用的资源。

相似文献

1
[Costs of ulcerative colitis within the German Statutory Health Insurance].[德国法定医疗保险体系中溃疡性结肠炎的费用]
Dtsch Med Wochenschr. 2010 Feb;135(7):281-6. doi: 10.1055/s-0029-1244848. Epub 2010 Feb 9.
2
[Costs of Crohn's disease in Germany from the perspective of the Statutory Health Insurance].[从法定健康保险角度看德国克罗恩病的成本]
Z Gastroenterol. 2009 Jul;47(7):659-66. doi: 10.1055/s-0028-1109059. Epub 2009 Jul 15.
3
Health care costs and their predictors of inflammatory bowel diseases in Germany.德国炎性肠病的医疗费用及其预测因素。
Eur J Health Econ. 2011 Jun;12(3):273-83. doi: 10.1007/s10198-010-0281-z. Epub 2010 Oct 22.
4
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.德国类风湿性关节炎的成本:基于医疗保健支付方数据源的微观成本核算方法。
Ann Rheum Dis. 2003 Jun;62(6):544-9. doi: 10.1136/ard.62.6.544.
5
Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.瑞士炎症性肠病住院患者年度健康资源利用及成本的系统分析。
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):868-875. doi: 10.1097/MEG.0000000000001160.
6
[Health economic impact of heart failure: An analysis of the nationwide German database].[心力衰竭的健康经济影响:对德国全国数据库的分析]
Dtsch Med Wochenschr. 2010 Apr;135(13):633-8. doi: 10.1055/s-0030-1251912. Epub 2010 Mar 23.
7
Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.德国炎症性肠病(IBD)患者的临床状况、心理社会障碍、治疗方法和医疗保健费用:一项在线 IBD 登记研究。
J Crohns Colitis. 2013 Jun;7(5):355-68. doi: 10.1016/j.crohns.2012.02.014. Epub 2012 Apr 12.
8
[Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital].[德国一家大学医院慢性炎症性肠病门诊治疗费用的测量]
Med Klin (Munich). 2002 Mar 15;97(3):128-36. doi: 10.1007/s00063-002-1136-x.
9
Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis.英国溃疡性结肠炎患者的医疗资源利用情况及相关费用:一项图表回顾性分析。
Eur J Gastroenterol Hepatol. 2014 Feb;26(2):213-21. doi: 10.1097/01.meg.0000435545.49133.cd.
10
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.美国儿童和成人克罗恩病及溃疡性结肠炎的直接医疗费用。
Gastroenterology. 2008 Dec;135(6):1907-13. doi: 10.1053/j.gastro.2008.09.012. Epub 2008 Sep 17.

引用本文的文献

1
Medication Burden Before and After Prescription of Biologics in Patients with Inflammatory Bowel Disease.炎症性肠病患者使用生物制剂前后的用药负担
J Clin Med. 2024 Oct 25;13(21):6408. doi: 10.3390/jcm13216408.
2
Timing of surgery in ulcerative colitis in the biologic therapy era-the patient's perspective.生物治疗时代溃疡性结肠炎的手术时机——患者视角
Int J Colorectal Dis. 2018 Oct;33(10):1429-1435. doi: 10.1007/s00384-018-3129-0. Epub 2018 Jul 12.
3
Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine.
德国溃疡性结肠炎治疗的成本效益:两种美沙拉嗪口服制剂的比较。
BMC Health Serv Res. 2011 Jul 5;11:157. doi: 10.1186/1472-6963-11-157.